Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 701–800 of 817
Microfluidics for Cells and Other Organisms
van Noort, D. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-563-8
Pang, Y., wang, C., Tang, J., & Zhu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-297925/v1
Noninvasive Screening for Aneuploidy Using Cell‐Free Placental DNA
Dugoff, L. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch7
Opportunities and Perspectives of NGS Applications in Cancer Research
Molina‐Aguilar, C., Vázquez‐Cruz, M. E., Olvera-León, R., & Robles‐Espinoza, C. D. (2021) · Learning materials in biosciences · doi:10.1007/978-3-030-62490-3_2
Pränataldiagnostik – Verfahren, Nutzung, Ziele
Kolleck, A. (2021) · Public Health Forum · doi:10.1515/pubhef-2021-0009
Circulating DNA Quantification
Hu, M. S., & Wang, Z. (2021) · Springer eBooks · doi:10.1007/978-981-16-1037-0_30
Kang, H. S., Wang, L., Li, X., Gao, C., Xie, Y., & Hu, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-846353/v1
Prenatal Diagnostic Techniques
Haugen, G. N., & Sitras, V. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108863049.013
Wang, Y., Wang, W., Wang, C., Li, S., Zhang, M., & Yin, C. (2021) · Research Square · doi:10.21203/rs.3.rs-1209282/v1
Genome‐Wide Cell‐Free DNA Screening Tests Go Beyond Scope of Traditional cfDNA Assays
(2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62274
Huang, X., & Liang, E. (2021) · Springer eBooks · doi:10.1007/978-981-16-1037-0_18
Cheung, H. H. C., Tong, L. Y., & To, W. W. K. (2022) · Hong Kong Journal of Gynaecology Obstetrics and Midwifery · doi:10.12809/hkjgom.22.1.02
Adipositas und Schwangerschaftsrisiken
Weichert, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-61906-3_6
rb (2019) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-019-0424-9
Wahłsten, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812832-9.00012-9
Wolfe, D. S., & Suskin, B. G. (2020) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610022255-03
(2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.026
Mathiesen, A. M., & Roy, K. B. (2018) · Oxford University Press eBooks · doi:10.1093/med/9780190681098.003.0003
Diagnóstico prenatal mediante muestra de sangre materna
Vivanti, A. J., Abgral, M., Benachi, A., & Costa, J. (2018) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(18)91439-6
Kagan, K. O., Abele, H., & Hoopmann, M. (2017) · Springer eBooks · doi:10.1007/978-3-662-53662-9_5 · Cited by 1
Zuckerwise, L. C., Archabald, K. L., & Copel, J. A. (2018) · Wiley eBooks · doi:10.1002/9781119072980.ch21
Response to USPTO’s Patent Eligibility Jurisprudence Study (Docket No.: PTO–P–2021–0032)Preprint
Aboy, M., Liddell, K., Crespo, C., Liddicoat, J., & Jordan, M. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3938183
Guerrero, M. H., Romero, J. P., Llanos, L. E., Huaman, M. A., & Kuan, A. D. (2022) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v68i2423
Screening for aneuploidies in first trimester: Overview and patient management
Tammaa, A., & Pashkunova, D. (2022) · Hamdan Medical Journal · doi:10.4103/hmj.hmj_41_22
Li, F., Liu, S., Chang, Q., Yang, F., Xu, Y., Jia, B., Wu, R., Li, L., Yin, A., Chen, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1560689/v1
Prenatal Screening: A Tool to Predict, Prevent, and Prepare
Sabu, B., & Ranganayaki, V. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105598 · Cited by 1
Genetics meets ultrasound: early prenatal screening for congenital anomalies
Bardi, F. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.245084236
Ju, J., Su, F., Chen, C., Sun, J., & Gao, Y. M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2819-5_17
Prenatal Diagnosis and Genetic Counseling
Schindewolf, E. M., & Moldenhauer, J. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-07524-7_2
Hirsig, L., Eklund, M. J., Wineland, R. J., Alkis, M. H., & Vidal, L. (2022) · Evidence-based imaging · doi:10.1007/978-3-030-38095-3_64-1
Fu, J., Zhong, X., Li, D., Ge, Y., & Zhang, X. (2023) · Journal of Medical Biochemistry · doi:10.5937/jomb0-33027
Tracking and Analysis of Initial Noninvasive Prenatal Testing Failure: A Retrospective StudyPreprint
Xie, J., Jiang, Y. L., Jin, D., Lu, X., Xia, Z., Huang, X., Wen, G., Zhou, Y., & Ge, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2554072/v1 · Cited by 1
Anwendung genetischer Untersuchungen in der Pränataldiagnostik
Manegold‐Brauer, G., Lapaire, O., Hösli-Krais, I., & Filges, I. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_7-2
Knight, A., & Miller, J. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192870957.003.0001
Wild, K. T., Sheppard, S. E., & Zackai, E. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00027-1
Prenatal Diagnosis and Counseling
CHENG, E. Y., & JACKSON, J. C. (2023) · Avery's Diseases of the Newborn · doi:10.1016/b978-0-323-82823-9.00026-x
Guven, S., CÖMERT, E. H., Güven, E. S. G., Bulent, D., & Karçaaltıncaba, D. (2023) · Clinical Journal of Obstetrics and Gynecology · doi:10.29328/journal.cjog.1001133
Prenatal gender selection: medical, ethical and psychological aspects
Kovalyova, O., & Mykytenko, D. (2023) · EUREKA Life Sciences · doi:10.21303/2504-5695.2023.002923
Prensky, L., & Persson, F. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6408
Genome-Wide Cell-Free Fetal DNA-Based Prenatal Testing: Limits and Perspectives
Bevilacqua, E., & Jani, J. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-31758-3_19
Overview and Historical Perspective of Preimplantation Genetic Testing
Simpson, J. L., Rechitsky, S., & Kuliev, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-31758-3_26
Chadha, K., Govalkar, A., Banerjee, M., Christy, A. L., Rajyadhyaksha, A., Jatale, R. G., Almeida, F., Chanekar, M., Gawali, Y., & Dixit, R. B. (2023) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2023.066
Ahmed, B., Abushma, M., & Konje, J. C. (2023) · Qeios · doi:10.32388/n2vrua
Park, J. E., Kang, K. M., Kim, H., Jang, H. Y., Go, M., Yang, S. H., Jeong, D., Jeong, H., Kim, J. C., Lim, S. Y., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13101468 · Cited by 2
Clifford, C. M., Askew, N., Smith, D., Iniguez, J., Smith, A. H., House, M. D., & Leech, A. A. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100293
Proto, A., Trottmann, F., Schneider, S., Amylidi-Mohr, S. K., Badiqué, F., Risch, L., Surbek, D., Raio, L., & Mosimann, B. (2024) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2202-5282 · Cited by 2
Bulanova, M. M., Smirnova, D. S., & Panina, O. B. (2024) · Ultrasound & Functional Diagnostics · doi:10.24835/1607-0771-2023-3-67-95
Murgia, F., Monni, G., Corda, V., Hendren, A. J., Paci, G., Piras, A., Ibba, R. M., & Atzori, L. (2024) · Authorea · doi:10.22541/au.170666497.75395940/v1
Gu, W., Talevich, E., Hsu, E. D., Qi, Z., Urisman, A., Federman, S. M., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715038
Gu, W., Talevich, E., Hsu, E. D., Qi, Z., Urisman, A., Federman, S. M., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715041
Gu, W., Talevich, E., Hsu, E. D., Qi, Z., Urisman, A., Federman, S. M., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715035
Gu, W., Talevich, E., Hsu, E. D., Qi, Z., Urisman, A., Federman, S. M., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715032
Karyotyping and Down Syndrome: Insights from Cytogenetic Analysis and Patient Data
Mukherjee, D. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.62206
Approaches to Prenatal Genetic Testing
Hopkins, M. K., Kuller, J. A., & Dugoff, L. (2024) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0001024380.96363.84
Routine antenatal care, antenatal testing and foetal therapy
Franx, A., Bekker, M. N., & Haak, M. C. (2024) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2994-6_22
Anwendung genetischer Untersuchungen in der Pränataldiagnostik
Manegold‐Brauer, G., Lapaire, O., Hösli-Krais, I., & Filges, I. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_7
Phillips, A. M., & Roy, K. B. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197677179.003.0003
Hirsig, L., Eklund, M. J., Wineland, R. J., Alkis, M. H., & Vidal, L. (2024) · Evidence-based imaging · doi:10.1007/978-3-030-89688-1_64
First-Trimester Cell-Free DNA Fetal Fraction and Birth Weight in Twin Pregnancies
Siegel, M., James, K. E., Bromley, B., Koelper, N., Chasen, S. T., Griffin, L. B., Roman, A. S., Limaye, M. A., Ranzini, A. C., Clifford, C. M., et al. (2024) · American Journal of Perinatology · doi:10.1055/a-2413-2353
Self-citationImproved contingent screening strategy increased trisomy 21 detection rate in the second trimester
Luo, W. P., He, B., Han, D., Yuan, L., Tang, J., Pang, L., Zhao, K., Zou, F., Hu, T., & Liu, S. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07743-4
Husseini, K. E. (2024) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(24)00054-5
A Dynamic Genetic Atlas of Gestational PhenotypesPreprint
Liu, S. M., Zheng, H., Gu, Y., Yang, Z., Zhen, J., Wei, Y., Liu, Y., Chen, Y., Wan, Z., Guo, X., et al. (2024) · medRxiv · doi:10.1101/2024.10.15.24315491
The Challenges of Down Syndrome Screening in Primary Healthcare for Pregnant Women in Iran in 2018
Zeinaloo, M., Shariati, M., Younesian, M., & Kheiltash, A. (2024) · Makara Journal of Health Research · doi:10.7454/msk.v28i2.1570
Emahazion, T., Badri, A., Jalkesten, E., Flodström‐Tullberg, M., Ajne, G., Uzunel, M., & Wikman, A. T. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5048704
Implementación del ADN libre circulante para la detección de aneuploidías fetales
Madrigal, I., Jodar, M., & Bádenas, C. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2024-0110 · Cited by 1
Implementation of circulating cell-free DNA screening for fetal aneuploidies
Madrigal, I., Jodar, M., & Bádenas, C. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2025-0055 · Cited by 2
Kagan, K. O., Abele, H., & Hoopmann, M. (2025) · Springer eBooks · doi:10.1007/978-3-662-67373-7_5
Revisión sistemática de las complicaciones perinatales en el síndrome de Down y su abordaje genético
Valencia, S. C., Vallejo, M. C., Beltrán, N., Rodríguez, L. M., García, S. N., González, J. G., Gómez, E. G., & Castañeda, J. E. Q. (2025) · Revista Salud Bosque · doi:10.18270/rsb.4825
Ahmed, B., Abushma, M., & Konje, J. C. (2023) · Qeios · doi:10.32388/n2vrua.2
Pathobiochemistry of inhibin A and its use in the screening of congenital developmental defects
Loucký, J., & Průša, R. (2020) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2020.003
Liquid Biopsy: Zirkulierende Tumor-DNA/RNA
von Bubnoff, N. C. C. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_152-1
Dhombres, F. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-78421-7.00020-8
Yang, X., Zhao, G., Zheng, J., & Jin, S. (2025) · Frontiers in Health Services · doi:10.3389/frhs.2025.1657703 · Cited by 3
Synthetic data-driven AI approach for fetal chromosomal aneuploidies detection
Hwang, C., Adhikari, K. P., Oh, G., & Kim, S. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbaf244
Circulating chromatin reveals the effects of disease-associated variants on gene regulationPreprint
Zhang, Z., Chhetri, S. B., Semaan, K., Zhang, Z., Jin, Z., Sotudian, S., Liang, L., Gusev, A., & Baca, S. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.12.688010
Dai, P., Yang, Y., Zhao, G., Gu, Z., Ren, H., Hu, S., Liu, N., Jiao, W., Li, J., & Kong, X. (2022) · Figshare · doi:10.6084/m9.figshare.20081028
Parsaei, M., Dashtkoohi, M., Salmani, T. A., Najafi, M. S., Haddadi, M., Ghaemi, M., & Hantoushzadeh, S. (2024) · Figshare · doi:10.6084/m9.figshare.26265130
Parsaei, M., Dashtkoohi, M., Salmani, T. A., Najafi, M. S., Haddadi, M., Ghaemi, M., & Hantoushzadeh, S. (2024) · Figshare · doi:10.6084/m9.figshare.26265016
Soster, E. L., Tynan, J. A., Gibbons, C., Meschino, W. S., Wardrop, J., Almasri, E., Schwartz, S., & McLennan, G. (2024) · Figshare · doi:10.6084/m9.figshare.26596313
Gu, W., Talevich, E., Hsu, E. D., Qi, Z. (., Urisman, A., Federman, S., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715044
Fang, M. T., Germani, F., Spitale, G., Wäscher, S., Kunz, L., & Biller‐Andorno, N. (2024) · Figshare · doi:10.6084/m9.figshare.26630596
Gu, W., Talevich, E., Hsu, E. D., Qi, Z. (., Urisman, A., Federman, S., Gopez, A., Arevalo, S., Gottschall, M., Liao, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14715029
Fang, M. T., Germani, F., Spitale, G., Wäscher, S., Kunz, L., & Biller‐Andorno, N. (2024) · Figshare · doi:10.6084/m9.figshare.26630593
张, 月. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123528
Wulveryck, C., Steijvoort, E. V., Sananès, N., Demailly, R., & Rodrigues, P. (2026) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2026.103109
Szenejko, P. I., Płotka, S., Wiechec, M. T., & Dąbrowski, F. (2026) · Research Square · doi:10.21203/rs.3.rs-8415161/v1
VENTAJAS Y LIMITACIONES DE LAS PRUEBAS GENÉTICAS PRENATALES NO INVASIVAS
Cuello, K. B. C., Vallejo, I. M. C., & Miranda, M. C. F. (2026) · Revista Politécnica de la Ciencia · doi:10.56519/xgpd9142
Retracted: Early Diagnosis of Rare Genetic Disorders Using AI-Powered Genomic Sequencing
Iram, F., Gopukumar, S. T., R, K. K., Ranjitha, B., Mubarak, S., & Jegajothi, B. (2025) · Global Conference on Information Technology and Communication Networks (GITCON) · doi:10.1109/gitcon65266.2025.11376862
RetractedPrenatal screening for common aneuploidies
Baranikumar, R., & Siddiqui, F. (2026) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2026.02.001
Circulating cell-free DNA in preeclampsia: predictive potential and insights into pathogenesis
Dong, H., Zhang, Y., & Zhang, B. (2026) · European journal of medical research · doi:10.1186/s40001-026-04238-7
Les acides nucléiques circulants : biomarqueurs d'intérêt en Assistance Médicale à la Procréation
Scalici, E. (2015) · theses.fr (ABES) · doi:10.70675/1618c116z4ef8z4fb0z8311z52db47edd7fe
Shortcomings in and preferred strategies for evaluating biomarkers as medical tests
Olsen, M. (2021) · theses.fr (ABES) · doi:10.70675/535e1627z1a35z437cz8c94z8701a5d0d2b7
Liu, H., Lin, S., & Yuan, K. (2026) · International Symposium on Computer Applications and Information Systems (ISCAIS) · doi:10.1109/iscait69154.2026.11477496
Prenatal genetic testing and potential consequences
Jauch, S. F., & Klaritsch, P. (2026) · Medizinische Genetik · doi:10.1515/medgen-2026-2008
Down Syndrome Therapy: Emerging Horizons in Chromosomal Deletion and Targeted Interventions
Kumar, D., & Rastogi, V. (2026) · Clinical Cancer Drugs · doi:10.2174/012212697x402101251126105313 · Cited by 1
Quality of Evidence for Prenatal Down Syndrome Screening: An Umbrella Review
Zhang, Y., Wang, Y., Wang, X., Liu, L., & Wang, K. (2026) · Prenatal Diagnosis · doi:10.1002/pd.70191
A digital microfluidic platform for cell-based non-invasive testing
Siriwardena, D., Dryden, M. D. M., Chamberlain, M. D., Taylor, C., Dupoiron, L., Gulati, S., Abbas, F., Lamanna, J., Chitayat, D., Wheeler, A. R., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116413
Genetic Analysis in Prenatal Diagnosis
Manegold‐Brauer, G., Lapaire, O., Hösli-Krais, I., & Filges, I. (2026) · Springer eBooks · doi:10.1007/978-3-662-70578-0_10
Savarese, P., Ronga, V., Rivetti, S., Simone, M. D., Coda, R., Quartotti, C., Copponi, L., Wu, J., Wu, D., Liu, X., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16142138
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.